Literature DB >> 25040758

Epicutaneous exposure to nickel induces nickel allergy in mice via a MyD88-dependent and interleukin-1-dependent pathway.

Marie T Vennegaard1, Beatrice Dyring-Andersen, Lone Skov, Morten M Nielsen, Jonas D Schmidt, Michael Bzorek, Steen S Poulsen, Allan R Thomsen, Anders Woetmann, Jacob P Thyssen, Jeanne D Johansen, Niels Odum, Torkil Menné, Carsten Geisler, Charlotte M Bonefeld.   

Abstract

BACKGROUND: Several attempts to establish a model in mice that reflects nickel allergy in humans have been made. Most models use intradermal injection of nickel in combination with adjuvant to induce nickel allergy. However, such models poorly reflect induction of nickel allergy following long-lasting epicutaneous exposure to nickel.
OBJECTIVE: To develop a mouse model reflecting nickel allergy in humans induced by epicutaneous exposure to nickel, and to investigate the mechanisms involved in such allergic responses.
METHODS: Mice were exposed to NiCl2 on the dorsal side of the ears. Inflammation was evaluated by the swelling and cell infiltration of the ears. T cell responses were determined as numbers of CD4+ and CD8+ T cells in the draining lymph nodes. Localization of nickel was examined by dimethylglyoxime staining.
RESULTS: Epicutaneous exposure to nickel results in prolonged localization of nickel in the epidermis, and induces nickel allergy in mice. The allergic response to nickel following epicutaneous exposure is MyD88-dependent and interleukin (IL)-1 receptor-dependent, but independent of toll-like receptor (TLR)-4.
CONCLUSION: This new model for nickel allergy that reflects epicutaneous exposure to nickel in humans shows that nickel allergy is dependent on MyD88 and IL-1 receptor signalling, but independent of TLR4.
© 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  IL-1 signalling; MyD88; TLR4; nickel allergy

Mesh:

Substances:

Year:  2014        PMID: 25040758     DOI: 10.1111/cod.12270

Source DB:  PubMed          Journal:  Contact Dermatitis        ISSN: 0105-1873            Impact factor:   6.600


  7 in total

Review 1.  Involvement of NF-κB/NLRP3 axis in the progression of aseptic loosening of total joint arthroplasties: a review of molecular mechanisms.

Authors:  Mohamad Qoreishi; Meysam Panahi; Omyd Dorodi; Naser Ghanbari; Saman Shakeri Jousheghan
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2022-04-04       Impact factor: 3.000

2.  Preclinical Efficacy of a Capsid Virus-like Particle-Based Vaccine Targeting IL-1β for Treatment of Allergic Contact Dermatitis.

Authors:  Louise Goksøyr; Anders B Funch; Anna K Okholm; Thor G Theander; Willem Adriaan de Jongh; Charlotte M Bonefeld; Adam F Sander
Journal:  Vaccines (Basel)       Date:  2022-05-23

Review 3.  Interplay of innate and adaptive immunity in metal-induced hypersensitivity.

Authors:  Amy S McKee; Andrew P Fontenot
Journal:  Curr Opin Immunol       Date:  2016-05-23       Impact factor: 7.486

Review 4.  Dendritic Epidermal T Cells in Allergic Contact Dermatitis.

Authors:  Veronika Mraz; Carsten Geisler; Charlotte Menné Bonefeld
Journal:  Front Immunol       Date:  2020-05-19       Impact factor: 7.561

5.  Suprabasin-null mice retain skin barrier function and show high contact hypersensitivity to nickel upon oral nickel loading.

Authors:  Shinsuke Nakazawa; Takatoshi Shimauchi; Atsuko Funakoshi; Masahiro Aoshima; Pawit Phadungsaksawasdi; Jun-Ichi Sakabe; Sanki Asakawa; Noriyasu Hirasawa; Taisuke Ito; Yoshiki Tokura
Journal:  Sci Rep       Date:  2020-09-03       Impact factor: 4.379

Review 6.  Roles and therapeutic potential of CD1d-Restricted NKT cells in inflammatory skin diseases.

Authors:  Sung Won Lee; Hyun Jung Park; Luc Van Kaer; Seokmann Hong
Journal:  Front Immunol       Date:  2022-09-02       Impact factor: 8.786

7.  Differential influence of Streptococcus mitis on host response to metals in reconstructed human skin and oral mucosa.

Authors:  Lin Shang; Dongmei Deng; Sanne Roffel; Susan Gibbs
Journal:  Contact Dermatitis       Date:  2020-08-31       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.